External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients

Background The advanced lung cancer inflammation index (ALI) was first introduced for prognosis prediction in lung cancer patients and since then evaluated in several other malignancies. However, in pancreatic cancer (PC) the ALI and its prognostic utility were only investigated in a comparably small and specific cohort of locally advanced PC patients treated with chemoradiotherapy. Methods In our single‐center cohort study, we included 429...